Affordable Access

deepdyve-link
Publisher Website

Men's experiences of radiotherapy treatment for localized prostate cancer and its long-term treatment side effects: a longitudinal qualitative study.

Authors
  • Sutton, E1
  • Lane, J A1, 2
  • Davis, M1
  • Walsh, E I1
  • Neal, D E3
  • Hamdy, F C3
  • Mason, M4
  • Staffurth, J5
  • Martin, R M1
  • Metcalfe, C1
  • Peters, T J1
  • Donovan, J L1, 6
  • Wade, J7
  • 1 Department of Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, Bristol, UK.
  • 2 Bristol Randomised Trials Collaboration, Population Health Sciences, Bristol Medical School, Canynge Hall, 39 Whatley Road, Clifton, Bristol, BS8 2PS, UK.
  • 3 Nuffield Department of Surgical Sciences, University of Oxford, Oxford, UK.
  • 4 Division of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK.
  • 5 Department of Oncology, Cardiff University, Cardiff, UK.
  • 6 National Institute for Health Research Collaboration for Leadership in Applied Health Research and Care (NIHR CLAHRC) West, University Hospitals Bristol NHS Trust, Bristol, UK.
  • 7 Department of Population Health Sciences, Bristol Medical School, University of Bristol, Canynge Hall, Bristol, UK. [email protected]
Type
Published Article
Journal
Cancer Causes & Control
Publisher
Springer-Verlag
Publication Date
Mar 01, 2021
Volume
32
Issue
3
Pages
261–269
Identifiers
DOI: 10.1007/s10552-020-01380-3
PMID: 33394204
Source
Medline
Keywords
Language
English
License
Unknown

Abstract

To investigate men's experiences of receiving external-beam radiotherapy (EBRT) with neoadjuvant Androgen Deprivation Therapy (ADT) for localized prostate cancer (LPCa) in the ProtecT trial. A longitudinal qualitative interview study was embedded in the ProtecT RCT. Sixteen men with clinically LPCa who underwent EBRT in ProtecT were purposively sampled to include a range of socio-demographic and clinical characteristics. They participated in serial in-depth qualitative interviews for up to 8 years post-treatment, exploring experiences of treatment and its side effects over time. Men experienced bowel, sexual, and urinary side effects, mostly in the short term but some persisted and were bothersome. Most men downplayed the impacts, voicing expectations of age-related decline, and normalizing these changes. There was some reticence to seek help, with men prioritizing their relationships and overall health and well-being over returning to pretreatment levels of function. Some unmet needs with regard to information about treatment schedules and side effects were reported, particularly among men with continuing functional symptoms. These findings reinforce the importance of providing universal clear, concise, and timely information and supportive resources in the short term, and more targeted and detailed information and care in the longer term to maintain and improve treatment experiences for men undergoing EBRT.

Report this publication

Statistics

Seen <100 times